AIL
ALLO icon

AGF Investments LLC’s Allogene Therapeutics ALLO Stock Holding History

AGF Investments LLC’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-26,012
Closed -$669K – 436
2021
Q3 		$669K Buy
26,012
+1,558
+6% +$37K 0.07% 76
2021
Q2 		$638K Buy
+24,454
New +$697K 0.07% 108
2020
Q3 		– Sell
-471
Closed -$20K – 552
2020
Q2 		$20K Buy
+471
New +$17K ﹤0.01% 468

Other funds holding ALLO

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AGF Investments LLC's ALLO Position: Q4 2021 in Review

AGF Investments LLC sold out of Allogene Therapeutics (ALLO) in Q4 2021, closing a stake of 26,012 shares — an estimated $669K sold.

AGF Investments LLC first reported a position in ALLO in Q2 2020 and held it in 3 quarters. The position peaked at $669K in Q3 2021. 177 funds tracked by Wall St. Rank hold ALLO as of Q4 2021.

  • AGF Investments LLC reported no remaining Allogene Therapeutics position as of Q4 2021 after selling out during the quarter.
  • AGF Investments LLC sold 26,012 Allogene Therapeutics shares in Q4 2021, an estimated $669K.
  • AGF Investments LLC first reported a position in Allogene Therapeutics in Q2 2020 and held it in 3 quarters.
  • AGF Investments LLC's Allogene Therapeutics position peaked at $669K in Q3 2021.
  • 177 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q4 2021.

Based on AGF Investments LLC's 13F filing for Q4 2021, filed 1 Feb 2022.